Serum concentration of C3 in primary lung cancer patients
Bariffi, F.; Marsico, S.A.; Vigorito, C.; Alfani, G.; Donato Di Paola, R.M.
Archivio Monaldi Per la Tisiologia E le Malattie Dell'apparato Respiratorio 35(4): 169-174
1980
ISSN/ISBN: 0004-0185 PMID: 6282231 Document Number: 159447
Document emailed within 1 workday
Related Documents
Kato, H.; Inoue, S.; Takahashi, K.; Yamanaka, A.; Okada, Y. 1987: UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 1): 1866-1870Kołomecki, K.; Maciaszczyk, P.; Stepień, H.; Cywiński, J.; Cielecka, J.; Stepień, T.; Kuzdak, K. 2006: Evaluation of p53 and soluble Fas ligand (sFasL) serum level concentration as indicators of apoptosis in serum of patients with benign and malignant primary follicular thyroid tumors Endokrynologia Polska 57(4): 320-325
Zhang, R.; Li, Y.; Chen, Y.; Liu, X.; Wang, Z.; Sun, H.; Zheng, Y.; Ding, Z.; Lan, L.; Li, M.; Qin, J.; Chen, X. 2015: Clinical implications of the concentration and EGFR/KRAS mutations of plasma cell free DNA of patients with lung cancer and esophageal cancer Zhonghua Yi Xue Za Zhi 95(47): 3839-3842
Greinert, U.; Ernst, M.; Haas, H.; Schlaak, M. 1989: Determination of immunologic parameters in patients with lung tuberculoses of various stages with special reference to serum IgE concentration Pneumologie 43(5): 254-258
Sasada, S.; Ukon, K.; Sato, Y.; Okusaki, K. 2013: A case of metastatic small intestinal tumor from primary lung cancer with hemorrhage and a high G-CSF serum level Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(6): 777-780
Villani, F.; Dell'Oca, I.; De Maria, P.; Viola, G.; Di Russo, A.; Viviani, S.; Bonfante, V. 1999: Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's disease Anticancer Research 19(5c): 4475-4479
Grützmacher, I.; Schicht, R.; Schlaeger, R.; Sill, V. 1984: Hemodynamics of pulmonary circulation in patients with chronic obstructive lung disease and pulmonary hypertension as dependent on the theophylline concentration of the serum Praxis und Klinik der Pneumologie 38(1): 19-25
Kolárová, M.; Tobiska, J.; Brada, Z. 1970: Host-tumour relationship. XXIX. Hyaluronidase activity and seromucoid concentration in blood serum of patients with cancer Neoplasma 17(6): 641-648
Larsen, K.R.; Grode, G.W.; Olsen, O.T. 1994: Primary lung cancer in patients under 40 years of age Ugeskrift for Laeger 156(20): 3018-3021
Osella, D.; Moschini, M.T.; Della Toffola, A.; Perino, A.; Giorgis, G.E.; Galietti, F. 1987: Assessment of IgE serum levels in lung cancer patients Panminerva Medica 29(1): 23-25
Miasoedov, D.V.; Krupko, I.N.; V'iunitskaia, L.V. 1984: Clinical significance of the serum concentration of carcino-embryonic antigen of stomach cancer patients at the preoperative examination stage Klinicheskaia Khirurgiia 5: 12-14
Pedersen, L.M.; Milman, N. 1998: The prognostic value of thrombocytosis in patients with primary lung cancer Ugeskrift for Laeger 160(26): 3917-3920
Miyamoto, T.; Inoue, M.; Tanemura, M.; Yamaguchi, M.; Irei, T.; Tamaru, K.; Seo, S.; Misumi, T.; Shimizu, W.; Suzuki, T.; Onoe, T.; Sudo, T.; Shimizu, Y.; Hinoi, T.; Tashiro, H. 2018: A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 88-90
Kurgan, J.; Szczepański, Z. 1977: Serum levels of alpha 1-antitrypsin in patients with lung cancer Pneumonologia Polska 45(8): 549-553
Arimura, Y.; Ashitani, J.-i.; Yanagi, S.; Tokojima, M.; Abe, K.; Mukae, H.; Nakazato, M. 2004: Elevated serum beta-defensins concentrations in patients with lung cancer Anticancer Research 24(6): 4051-4057
Greinert, U.; Ernst, M.; Haas, H.; Lepp, U.; Schlaak, M. 1990: Increased serum IgE concentration in lung tuberculosis Pneumologie 44(Suppl 1): 495-496
Schreiber, G.; Pitterle, D.; Kim, Y.C.; Bepler, G. 1999: Molecular genetic analysis of primary lung cancer and cancer metastatic to the lung Anticancer Research 19(2a): 1109-1115
Nishimura, H.; Morimoto, M.; Haniuda, M.; Masai, M.; Kobayashi, O.; Yamanda, T.; Aoki, T.; Iida, F. 1992: Results of patients in stage I and II primary lung cancer with curative resection Kyobu Geka. Japanese Journal of Thoracic Surgery 45(7): 582-585
Quillien, V.; Ramee, M.P.; Bansard, J.Y.; Meritte, H.; Briens, E.; Logeais, Y.; Langanay, T.; Corbineau, H.; Dazord, L. 1995: Serum and tissue distribution of a fragment of cytokeratin 19 (cyfra 21-1) in lung cancer patients Anticancer Research 15(6b): 2857-2863
Kas'ianenko, I.V.; Zatula, D.G.; Piviniuk, V.M.; Sytenko, V.K.; Siadro, T.I. 1974: Diagnostic evaluation of the bacteriolytic capacity of the blood serum in patients with lung cancer Vrachebnoe Delo 3: 122-124